Emerging evidence suggests that ceramide activation plays a crucial role in triggering caspase-1 activation and IL-1β production via the NLRP3 inflammasome pathway, contributing to pathological conditions like obesity, podocyte damage, and acute lung injury [14,25,69,70]. Here, NLRP3 is linked to obesity disorder.